返回
Acute Lymphoblastic Leukemia
DOI:10.6004/jnccn.2012.0089.png)
摘要
En 中文
The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL. (JNCCN 2012;10:858-914)
Keyword:
MINIMAL RESIDUAL DISEASE
STEM-CELL TRANSPLANTATION
CHRONIC MYELOID-LEUKEMIA
NERVOUS-SYSTEM INVOLVEMENT
CHILDRENS-ONCOLOGY-GROUP
TERM-FOLLOW-UP
BONE-MARROW-TRANSPLANTATION
ACUTE LYMPHOCYTIC-LEUKEMIA
THERAPY IMPROVES SURVIVAL
POLYMERASE-CHAIN-REACTION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
引用论文
暂无论文信息



